Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [ 11 C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism
Molecular Imaging · 01.01.2017 · 16
DOI: 10.1177/1536012117734485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Imaging, online erschienen am 26.10.2017. Verfasst von Nana L Christensen und 8 weiteren Autor:innen. Beteiligte Einrichtung: 1 Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Aarhus C, Denmark. Hauptthemen laut MEDLINE: Metabolome, Positron-Emission Tomography, Radiometry. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Despite the decades long use of [ 11 C]palmitate positron emission tomography (PET)/computed tomography in basic metabolism studies, only personal communications regarding dosimetry and biodistribution data have been published.
Methods
Dosimetry and biodistribution studies were performed in 2 pigs and 2 healthy volunteers by whole-body [ 11 C]palmitate PET scans. Metabolite studies were performed in 40 participants (healthy and with type 2 diabetes) under basal and hyperinsulinemic conditions. Metabolites were estimated using 2 approaches and subsequently compared: Indirect [ 11 C]CO 2 release and parent [ 11 C]palmitate measured by a solid-phase extraction (SPE) method. Finally, myocardial fatty acid uptake was calculated in a patient cohort using input functions derived from individual metabolite correction compared with population-based metabolite correction.
Results
In humans, mean effective dose was 3.23 (0.02) µSv/MBq, with the liver and myocardium receiving the highest absorbed doses. Metabolite correction using only [ 11 C]CO 2 estimates underestimated the fraction of metabolites in studies lasting more than 20 minutes. Population-based metabolite correction showed excellent correlation with individual metabolite correction in the cardiac PET validation cohort.
Conclusion
First, mean effective dose of [ 11 C]palmitate is 3.23 (0.02) µSv/MBq in humans allowing multiple scans using ∼300 MBq [ 11 C]palmitate, and secondly, population-based metabolite correction compares well with individual correction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1 Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Aarhus C, Denmark.
- 2 Department of Endocrinology, Aarhus University Hospital, Aarhus C, Denmark.
Zitieren
APA
Christensen, N. L., Jakobsen, S., Schacht, A. C., Munk, O. L., Alstrup, A. K. O., Tolbod, L. P., Harms, H. J., Nielsen, S., & Gormsen, L. C. (2017). Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [ 11 C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism. Molecular Imaging, 16. https://doi.org/10.1177/1536012117734485
Vancouver
Christensen NL, Jakobsen S, Schacht AC, Munk OL, Alstrup AKO, Tolbod LP, et al. Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [ 11 C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism. Molecular Imaging. 2017;16. doi:10.1177/1536012117734485
BibTeX
@article{Christensen2017,
author = {Christensen, Nana L and Jakobsen, Steen and Schacht, Anna C and Munk, Ole L and Alstrup, Aage K O and Tolbod, Lars P and Harms, Hendrik J and Nielsen, Søren and Gormsen, Lars C},
title = {Whole-Body Biodistribution, Dosimetry, and Metabolite Correction of [ 11 C]Palmitate: A PET Tracer for Imaging of Fatty Acid Metabolism},
journal = {Molecular Imaging},
year = {2017},
volume = {16},
doi = {10.1177/1536012117734485}
}
EUVIMED